RateGain Travel Technologies Limited has announced the approval of equity share grants under its Employee Stock Purchase Scheme 2023, demonstrating the company's commitment to employee participation in its growth story. The Nomination and Remuneration Committee approved this significant employee benefit initiative on March 26, 2026.

Share Grant Details

The committee has approved the grant of 67,631 equity shares under the RateGain Employee Stock Purchase Scheme 2023. This grant represents a substantial allocation aimed at incentivizing and retaining key talent within the organization.

Vesting and Lock-in Structure

The scheme incorporates a comprehensive 4-year vesting schedule designed to ensure long-term employee commitment. The structured release mechanism provides graduated access to the granted shares over the vesting period.

The shares will be subject to a 4-year lock-in period, with releases following the above schedule. Employees will have a 3-year exercise period to purchase their allocated shares at the predetermined price of Rs. 750 per share.

Regulatory Compliance

The grant has been executed in full compliance with regulatory requirements, including Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company has formally notified both the National Stock Exchange of India Limited and BSE Limited about this corporate action.

This employee stock purchase scheme reflects RateGain Travel Technologies' strategy to align employee interests with shareholder value creation while maintaining strict adherence to regulatory frameworks governing employee benefit schemes.

RateGain travel Technologies Limited has successfully allotted 41,309 equity shares to eligible employees under two employee benefit schemes. The Nomination and Remuneration Committee approved this allotment on March 26, 2026, pursuant to the company's Stock Appreciation Rights Scheme 2022 and Employee Stock Option Scheme 2015.

Share Allotment Details

The allotment encompasses shares distributed across two distinct employee benefit schemes with varying terms and conditions:

Impact on Share Capital

The allotment has resulted in a measurable increase in the company's equity base. The paid-up equity share capital has expanded from Rs. 118,124,117 to Rs. 118,165,426, representing the addition of 41,309 new equity shares of Re. 1 face value each.

Regulatory Compliance

The allotment was conducted in accordance with SEBI regulations and listing requirements. Key compliance aspects include:

• Disclosure made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015
• Filing completed with both BSE Limited and National Stock Exchange of India Limited
• Detailed disclosure provided as per Part E of Schedule I of Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021

Share Characteristics

The newly allotted equity shares carry identical rights and privileges as existing shares. All shares issued under both schemes rank pari-passu with the company's existing equity shares, ensuring uniform treatment for all shareholders. The shares are issued in dematerialized form under ISIN INE0CLI01024, with no lock-in restrictions applicable to the allotted shares.